ODX.L Share News (ODX)

TRADING UPDATES: Indivior, Diurnal start trials; Alien Metals tests

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

UK shareholder meetings calendar - next 7 days

IN BRIEF: Omega raises GBP2.0 million through placing and subscription

Omega Diagnostics Group PLC - Alva, Scotland-based diagnostics company - Raises gross proceeds of GBP2.0 million via a placing of 50.0 million new shares and the issue of 90.0 million warrants at a price of 4.0 pence per share. Plans to use the proceeds to fund its CD4 business to divestment and provide additional working capital. Intends to dispose of the CD4 unit to focus solely on its Health & Nutrition business which contributes to the majority of its revenue. Plans to raise an additional GBP2.0 million by the issue of up to 49.9 million shares through an open offer. Expects its enlarged issued share capital to be 284.7 million shares, assuming full take-up of the open offer shares.

IN BRIEF: Omega Diagnostics expects substantial annual revenue growth

Omega Diagnostics Group PLC - Alva, Scotland-based diagnostics company - Expects to report revenue of GBP12.3 million for the year ended March 31, up 41% from GBP8.7 million the year before. Says Covid-19-related revenue grew 53% to GBP2.6 million from GBP1.7 million. Expects ongoing Covid-related income to be minimal. Notes that net cash balance was GBP1.5 million at year-end and that it has an overdraft facility of GBP2.0 million which remains in place and unutilised. Continues to actively explore alternative options to generate additional funds.

Omega Diagnostics FY revenues surge, sees 'minimal' ongoing Covid income

(Sharecast News) - Medical diagnostics company Omega said on Thursday that full-year revenues were expected to have surged in 2021 but cautioned that ongoing Covid-related income was now anticipated to be minimal.

Omega's professional-use Covid test rejected by UK regulator

(Sharecast News) - Omega Diagnostics announced another disappointment for its Covid-19 tests on Friday, announcing that the UK Health Security Agency said its application for approval of the professional-use 'VISITECT' antigen test under the Coronavirus Test Device Approvals regulations (CTDA) was unsuccessful.

AIM WINNERS & LOSERS: Omega Diagnostics Visitect not available in UK

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

IN BRIEF: Omega completes conditional sale of manufacturing business

Omega Diagnostics Group PLC - Alva, Scotland-based medical diagnostics - Says it has completed the conditional sale agreement for Omega's diagnostic test kit manufacturing business and facility in Alva, Scotland. Agreement is with Accubio Ltd, a wholly-owned subsidiary of Zhejiang Orient Gene Biotech Co Ltd for a cash consideration of GBP1 million.

TRADING UPDATES: Hutchmed in Macau boost; UP Global success in Germany

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Omega selling Scotland factory after government Covid test plans collapse

(Sharecast News) - Medical diagnostics specialist Omega has signed a conditional sale and purchase agreement with Accubio, a wholly-owned subsidiary of Orient Gene, for the sale of its diagnostic test kit manufacturing business and facility in Alva, Scotland.

Omega shares down on discounted fundraise; sells Alva facility

(Alliance News) - Omega Diagnostics Group PLC on Friday announced that it had begun a GBP7.0 million fundraise as well as sold its manufacturing business in Alva, Scotland.

IN BRIEF: Omega Diagnostics confirms plan for GBP7 million fundraise

IN BRIEF: Omega Diagnostics confirms plan for GBP7 million fundraise

Omega gets CE-marking for Covid-19 test, working on UK approval

(Sharecast News) - Medical diagnostics specialist Omega has successfully CE-marked its 'Visitect' Covid-19 antigen test for self-test use, it announced on Thursday.

IN BRIEF: Omega Diagnostics shares up on CE mark for Covid-test

IN BRIEF: Omega Diagnostics shares up on CE mark for Covid-test

AIM WINNERS & LOSERS: Omega Covid test gets CE mark; Creo revenue up

AIM WINNERS & LOSERS: Omega Covid test gets CE mark; Creo revenue up